Search Orphan Drug Designations and Approvals
-
| Generic Name: | aptamer-drug conjugate (ApDC) comprising a c-Met aptamer (SL1) and linker-payload (vcMMAE) |
|---|---|
| Date Designated: | 09/17/2024 |
| Orphan Designation: | treatment of uveal melanoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Hangzhou Institute of Medicine, Chinese Academy of Sciences Fucheng Road 150, Qiantang District Hangzhou, Zhejiang China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







